Protocols/Clinical Trials
Active Studies
| Protocol # | Protocol Name | Status |
|---|---|---|
| ACTG A5239 | A Pilot Study of Therapy with Pioglitazone Prior to HCV Treatment in HIV-! And HCV Genotype 1 Infected Subjects with Insulin Resistance Who Are Prior Nonresponders to Peginterferon and RBV | Enrolling |
| ACTG A5240 | Phase II Study to Evaluate the Immunogenicity and Safety of Gardasil in HIV-1-Infected Females with a HIV RNA>10,000 or CD4 count <200 and HIV RNA<10,000 | Enrolling |
| ACTG A5241 | Open label Phase III Trial for subjects failing their Current regime with a Viral Load >1000 and Treatment Experience with NRTI’s, NNRTI’s and PI’s. Subjects will be randomized to add NRTI’s or not add NRTI’s to a new effective regime using the cPSS. | Enrolling |
| ACTG A5247 | Phase II study to Evaluate the Safety, Tolerability And Immunogenicity of ZOSTAVAX in Subjects with A CD4 count of 200-349 and an Undetectable Viral Load | Enrolling |
| ACTG A5252 | Phase II Study for the Treatment of HIV-Associated Painful Peripheral Neuropathy in a Double Blind, Placebo Controlled study of Duloxetine and methadone | Enrolling |
| ACTG A5257 | Phase III Comparative Study of Three NNRTI Sparing ART’s for Treatment Naïve HIV-1 Subjects randomized to Atazanavir or Raltegravir or Darunavir plus Truvada | Enrolling |
| Other NIH sponsored studies include: | ||
| Hearing Impairment in HIV/AIDS | The study is enrolling 360 HIV +participants from the ID clinic who will have their hearing tested 6 times over a 4 year period. | Enrolling |
For More Information
Please feel free to contact Carol Greisberger at (585) 275-2740.
